arrow
G

Gavin W. Collie

AstraZeneca
H指数:23
被引数:2,614

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction to “Targeting the Interaction of NRF2 and β-TrCP with Molecular Glues”

对“靶向NRF2和β-TrCP相互作用的分子胶”的更正

2026-05-270
PRE
A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degrader

二氢尿嘧啶CRBN配体减轻了异双功能靶向蛋白降解物中IMiD相关的安全责任

2026-03-250
OAAI
Discovery and Characterization of Diverse Non-nucleotide Inhibitors of DNPH1 Using an Integrated Hit Finding Strategy
2025-12-010
PRE
Discovery and Optimization of a Non-Nucleoside-Based Series of Inhibitors of 2′-Deoxynucleoside 5′-Monophosphate Glycosidase (DNPH1)

发现和优化一类非核苷类2′-脱氧核苷-5′-单磷酸糖苷酶(DNPH1)抑制剂

2025-11-060
PRE
Fragment-Based Discovery of Novel MUS81 Inhibitors

基于片段的新型MUS81抑制剂的发现

2024-06-070
OAAI
Identification of Novel Potent NSD2-PWWP1 Ligands Using Structure-Based Design and Computational Approaches
2024-05-154
PRE
Discovery and Optimization of the First ATP Competitive Type-III c-MET Inhibitor
2023-06-218
OAAI
Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assays
2022-11-037
OAAI
Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 Inhibitors
2022-06-0311
OAAI
Into Deep Water: Optimizing BCL6 Inhibitors by Growing into a Solvated Pocket
2021-11-3010
OAAI